slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 61,651-61,680
Pages 2,605
Rows per page 30
Component
61,651-61,680 of 78,138
15
The chart uses a dual-axis line graph to show the inverse relationship between total corporate bond stock and primary dealer inventory.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
16
The slide uses a stacked bar chart to illustrate a structural shift in investment strategy.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations Beat · Solution1 hit
22
The slide highlights the scale of the origination platform and its ability to generate recurring assets.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations Beat · Solution1 hit
23
The chart shows historical growth from 2020 to 2022 and a 2026 target.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations Beat · Solution1 hit
29
The chart highlights specific transaction events (Jackson, JCPenney, Lockheed Martin) and market conditions (COVID-19, UK LDI Turmoil) to demonstrate resilience and opportunistic growth.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
31
The slide highlights that Athene maintains a lower leverage ratio (9.8x) compared to its industry peers (10.3x - 14.3x).Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
33
The chart uses a waterfall-like structure to decompose 100% of liabilities into four distinct categories.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
36
The chart uses a shaded region to denote the GFC period (roughly 2Q08 to 1Q09).Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
37
The slide uses a donut chart to represent asset allocation and highlights key quality metrics.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
50
The slide uses a donut chart to break down the $184B liability portfolio by product type.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
05
The chart uses a Gantt-style visualization to represent drug development stages.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
09
Includes a schematic of the GalNAc-linker-RNAi construct and a bar chart illustrating the suppression of various HBV transcripts.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
12
The slide displays longitudinal data for cohorts E, F, I, J, G, and K, highlighting individual patient responses and key clinical outcomes.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
13
The slide displays 8 individual patient case studies (Pt 46, 51, 52, 53, 56, 58, 59, 60, 61).Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses a waterfall-style bar chart to show quarterly revenue progression, though it is technically a standard bar chart.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Loop · Why Now1 hit
09
argenx SE | Results Presentation Deck | 11 slidesargenx SE | Results Presentation Deck | 11 slides · argenx
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
08
The slide uses a dual-axis chart to show revenue growth alongside emission reduction. It highlights specific targets for 2025 and 2026.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future VisionLoop · Golden Circle1 hit
05
The slide uses a Gantt-style visualization to show the progress of drug development programs.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
08
The slide uses a vertical timeline-like structure to highlight the 'Huge Need for Development' and a map/metric section for global impact.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
09
Includes a quote from Keith Nuechterlein and specific Cohen's d effect size metrics.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
16
The slide uses a line chart to show MADRS score changes over 12 weeks, highlighting the 25mg dose efficacy.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
18
The slide uses a split layout: a dark sidebar for product specs and a white main area for clinical data visualization.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
22
The slide uses a split-layout with a left-hand sidebar for product specs and a right-hand main area for clinical evidence and trial design.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
24
The slide uses topographical brain maps to visualize EEG data changes.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
25
The chart uses error bars and statistical significance markers (asterisks) to compare dose groups against a zero baseline.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
29
The slide uses a line chart to demonstrate reduction in HCQN subscales over time, and a process diagram to outline the ongoing Phase 1/2 trial stages.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
26
Uses a value chain comparison to illustrate market efficiency.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations 1 hit
05
BenevolentAI | Results Presentation Deck | 38 slidesBenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations 1 hit
15
The chart uses a horizontal bar format to show progression through Target ID, Lead Opt, Preclinical, Phase I, and Phase II.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · Traction1 hit
26
The slide is split into two sections: team composition on the left and board members on the right.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations 1 hit